Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL)

K-Number: K210287 · 2021-10-28

Decision Date2021-10-28
Product CodeLON
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) is a medical device manufactured by bioMerieux, Inc.. It received FDA 510(k) clearance on 2021-10-28 under approval number K210287. The device is classified under product code LON. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL)?

VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) is a medical device that received FDA 510(k) clearance on 2021-10-28. It is manufactured by bioMerieux, Inc.. The 510(k) number is K210287.

When was VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) approved by the FDA?

VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) received FDA 510(k) clearance on 2021-10-28, under approval number K210287.

What company makes VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL)?

VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) is manufactured by bioMerieux, Inc..

What is the FDA product code for VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL)?

The FDA product code for VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) is LON.

Other Devices by bioMerieux, Inc.

View all 66 devices →

Related Devices (Code: LON)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.